Cryoablation of atrial fibrillation in “very severe” obese patients (BMI ≥ 40): Indications, feasibility, procedural safety and efficacy, and clinical outcome (the ICE‐Obese Extreme)

Cryoablation of atrial fibrillation in “very severe” obese patients (BMI ≥ 40): Indications, feasibility, procedural safety and efficacy, and clinical outcome (the ICE‐Obese Extreme)

Background Management of atrial fibrillation (AF) in very severe obese patients is challenging. Cryoballoon ablation (CBA) represents an effective rhythm control strategy. However, data in this patient group were limited. Methods Highly symptomatic AF patients with body mass index (BMI) ≥ 40 kg/m2 w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiovascular electrophysiology 2024-07, Vol.35 (7), p.1412-1421
Hauptverfasser: Urbanek, Lukas, Schmidt, Boris, Bordignon, Stefano, Schaack, David, Ebrahimi, Ramin, Tohoku, Shota, Hirokami, Jun, Efe, Tolga Han, Plank, Karin, Schulte‐Hahn, Britta, Nowak, Bernd, Chun, Julian K. R., Chen, Shaojie
Format: Artikel
Sprache:eng
Schlagworte:
Ablation
atrial fibrillation
BMI
Body mass index
Cardiac arrhythmia
cryoablation
cryoballoon
Drug therapy
Fibrillation
Fluoroscopy
obesity
pulmonary vein isolation
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Management of atrial fibrillation (AF) in very severe obese patients is challenging. Cryoballoon ablation (CBA) represents an effective rhythm control strategy. However, data in this patient group were limited. Methods Highly symptomatic AF patients with body mass index (BMI) ≥ 40 kg/m2 who had failed antiarrhythmic drug therapy and electrocardioversion and failure to achieve targeted body‐weight‐reduction underwent CBA. Results Data of 72 very severe obese AF patients (Group A) and 129 AF patients with normal BMI (Group B, BMI 
ISSN:1045-3873
1540-8167
1540-8167
DOI:10.1111/jce.16302